GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO)

NSE: GLAXO Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	11,100	641.71	349.41	2,862	4,052	1,048
Short-Term Investments	10,008	9,794	11,009	21,791	7,320	9,570
Trading Asset Securities	-	8,132	5,183	3,656	-	-
Cash & Short-Term Investments	21,108	18,568	16,541	28,309	11,372	10,618
Cash Growth	31.49%	12.25%	-41.57%	148.94%	7.10%	-7.49%
Accounts Receivable	2,684	2,221	1,924	2,052	2,156	998.01
Other Receivables	-	1,275	1,373	715.31	254	306.15
Receivables	2,684	3,496	3,297	2,768	2,410	1,304
Inventory	5,176	5,250	4,600	5,347	5,467	4,830
Prepaid Expenses	-	206.18	149.6	139.26	146.49	117.89
Other Current Assets	1,175	463.33	355.04	517.62	2,631	878.19
Total Current Assets	30,144	27,984	24,943	37,080	22,026	17,749
Property, Plant & Equipment	2,976	3,107	3,151	3,254	3,554	8,271
Long-Term Investments	-	0.27	0.27	0.15	0.15	-
Other Intangible Assets	183.4	235.54	340.91	344.97	433.64	496.25
Long-Term Deferred Tax Assets	1,503	1,463	1,335	1,131	1,031	1,105
Other Long-Term Assets	2,654	2,776	2,795	2,621	4,101	3,712
Total Assets	37,460	35,566	33,266	46,333	31,146	31,332
Accounts Payable	6,305	6,254	4,278	5,793	4,661	3,571
Accrued Expenses	-	1,655	1,482	4,622	2,066	1,533
Current Portion of Long-Term Debt	-	-	-	-	0.24	1.53
Current Portion of Leases	106.1	121.96	120.84	124.53	143.53	148.26
Current Income Taxes Payable	5,391	2,986	2,962	2,962	1,637	1,614
Current Unearned Revenue	-	-	-	-	1,800	-
Other Current Liabilities	6,330	4,233	4,421	3,483	3,238	3,352
Total Current Liabilities	18,132	15,249	13,264	16,984	13,546	10,220
Long-Term Debt	-	-	-	-	-	0.24
Long-Term Leases	41.8	64.69	34.55	76.24	202.5	268.37
Other Long-Term Liabilities	2,559	1,673	1,761	1,848	1,817	1,792
Total Liabilities	20,733	17,790	15,853	19,703	16,364	13,126
Common Stock	1,694	1,694	1,694	1,694	1,694	1,694
Retained Earnings	-	16,351	15,920	25,210	13,345	16,540
Comprehensive Income & Other	15,033	-268.57	-201.58	-274.96	-256.9	-28.22
Shareholders' Equity	16,727	17,776	17,413	26,630	14,783	18,206
Total Liabilities & Equity	37,460	35,566	33,266	46,333	31,146	31,332
Total Debt	147.9	186.65	155.39	200.77	346.27	418.4
Net Cash (Debt)	20,960	18,382	16,386	28,108	11,026	10,200
Net Cash Growth	32.33%	12.18%	-41.70%	154.93%	8.10%	-11.09%
Net Cash Per Share	123.72	108.51	96.73	165.92	65.08	60.21
Filing Date Shares Outstanding	172.12	169.41	169.41	169.41	169.41	169.41
Total Common Shares Outstanding	172.12	169.41	169.41	169.41	169.41	169.41
Working Capital	12,012	12,735	11,679	20,096	8,481	7,529
Book Value Per Share	97.18	104.93	102.79	157.19	87.26	107.47
Tangible Book Value	16,544	17,541	17,072	26,285	14,349	17,710
Tangible Book Value Per Share	96.12	103.54	100.77	155.16	84.70	104.54
Land	-	36.8	36.8	22.49	22.49	560.11
Buildings	-	1,099	1,084	1,041	1,022	4,412
Machinery	-	4,489	4,244	3,937	3,915	8,213
Construction In Progress	-	139.3	203.12	305.02	132.14	1,201

Source: S&P Capital IQ. Standard template. Financial Sources.